Sponsor Pipeline

GrandPharma (China) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07334483 A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy… HCC Recruiting
Phase 1
NCT07045428 68Ga-GP-01 Injection in Solid Tumors Participants Solid Tumor Malignancies Not Yet Recruiting
Not specified
NCT06079242 Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic… Colorectal Neoplasms Not Yet Recruiting
NCT06712017 Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China Hepatocellular Carcinoma (HCC) Enrolling by Invitation
Disease Areas
Get alerts when GrandPharma (China) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free